1. Beurtheret, S., Mordant, P., Paoletti, X., Marijon, E., Celermajer, D.S., Léger, P., Pavie, A., Combes, A., and Leprince, P. (2013). Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac–RESCUE program). Eur Heart J 34, 112–120.
2. Botero, V., García, V.H., Aristizabal, A.M., Gomez, C., Perez, P., Caicedo, L.A., and Echeverri, G.J. (2018). Hepatitis A, cardiomyopathy, aplastic anemia, and acute liver failure: A devastating scenario. Transpl Infect Dis 20, e12842.
3. Bratincsák, A., El–Said, H.G., Bradley, J.S., Shayan, K., Grossfeld, P.D., and Cannavino, C.R. (2010). Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children. J Am College Cardiology 55, 928–929.
4. Brucato. A., Colombo, T., Bonacina, E., Orcese, C., Vago, L., Oliva, F., Distefano, G., Frigerio, M., Paino, R., and Violin, M. (2004). Fulminant myocarditis during HIV seroconversion: recovery with temporary left ventricular mechanical assistance. Ital Heart J 5, 228.
5. Chinese Society of Cardiology. (2017). Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis. Chin J Cardiol 45, 742–752.